SCHEMBL29118643

SCHEMBL29118643

NNc1ncnc2ccoc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.49
SMN1; SMN2 Q16637 4/20 0.33
HTT P42858 4/20 0.33
RAB9A P51151 1/20 0.33
HIF1A Q16665 1/20 0.33
PIK3CD O00329 1/20 0.32
PIK3R2 O00459 1/20 0.32
POLB P06746 1/20 0.31
LMNA P02545 3/20 0.31
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
NOD2 Q9HC29 1/20 0.31
PAK4 O96013 1/20 0.30
OPRM1 P35372 1/20 0.30
OPRD1 P41143 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30748895 0.81 IRAK4 (0.52) IRAK4SMN1; SMN2PIK3CDPIK3R2LMNA
SCHEMBL1789394 0.74 PI4KA (0.42) IRAK4SMN1; SMN2POLBALDH1A1KDM4E
Hydrochloric Acid SCHEMBL30791008 0.72 PI4KA (0.41) IRAK4SMN1; SMN2POLBALDH1A1KDM4E
SCHEMBL21187403 0.72 IRAK4 (0.69) IRAK4HTTLMNAALDH1A1MAPK1
SCHEMBL1369046 0.71 PDE4A (0.43) IRAK4SMN1; SMN2PIK3CDPIK3R2LMNA
SCHEMBL6126372 0.71 IRAK4 (0.41) IRAK4RAB9APOLBLMNAALDH1A1
SCHEMBL20265607 0.71 ASIC3 (0.51) ALDH1A1KDM4EMAPTOPRM1DYRK1A
SCHEMBL12559881 0.69 IRAK4 (0.39) IRAK4
SCHEMBL12143633 0.69 IRAK4 (0.42) IRAK4HIF1ALMNATSHRCLK4
SCHEMBL2971145 0.69 IRAK4 (0.39) IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116731030-A Synthesis method and antitumor application of several furopyrimidine-ibuprofen hybrid derivatives 湖北医药学院 2023-09-12 CN disclosed